Padmashree Gehl Sampath is currently Senior Fellow, Harvard Kennedy School and the Founding Chief Executive Officer of the African Pharmaceutical Technology Foundation. She is also Visiting Professor of Practice at the London School of Economics (UK), Honorary Professor at the University of Rwanda, and a member of the Trade and Industrial Development Advisory Council of the African Continental Free Trade Area (AfCFTA) Secretariat. Until recently she was also the Senior Advisor to the President of the African Development Bank on Pharmaceuticals and Health. She has over 25 years of expertise in international relations and public policy having worked extensively on technology and industrial development.
Padmashree Gehl Sampath
By this expert
Are We Reforming Global Health or Washing Our Hands Of It?
Global health financing is collapsing just as demands on health systems are rising. As funding retreats and reform debates intensify, a deeper question emerges about who bears the costs, and whether today’s fixes risk creating lasting damage that will be difficult to reverse.
Transforming Corporate Governance to Improve Access to Medicines in the Global South
Affordable medicines remain out of reach for millions because pharmaceutical innovation is organized around value extraction, not public health. How do shareholder-driven governance and fragmented global health financing reinforce inequity, and what structural reforms are needed to reverse it?
Biopharmaceutical Innovation: Corporate Governance for Equitable Global Health
The global medicine-access crisis is not simply a failure to balance innovation and affordability. It reflects a deeper system in which shareholder-driven pharmaceutical governance and fragmented donor structures undermine public health and block the shift toward more equitable value creation.